Simplex Trading’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,900
Closed -$9K 9520
2025
Q1
$9K Hold
6,900
﹤0.01% 7193
2024
Q4
$18K Buy
6,900
+5,000
+263% +$15.9K ﹤0.01% 6772
2024
Q3
$3K Hold
1,900
﹤0.01% 7876
2024
Q2
$3K Buy
1,900
+300
+19% +$582 ﹤0.01% 8145
2024
Q1
$3K Buy
1,600
+600
+60% +$1.28K ﹤0.01% 8297
2023
Q4
$1K Sell
1,000
-6,500
-87% -$9.99K ﹤0.01% 8558
2023
Q3
$9K Sell
7,500
-4,700
-39% -$7.39K ﹤0.01% 7265
2023
Q2
$19K Sell
12,200
-123,900
-91% -$242K ﹤0.01% 6841
2023
Q1
$289K Buy
136,100
+105,400
+343% +$322K ﹤0.01% 3880
2022
Q4
$113K Buy
30,700
+29,300
+2,093% +$38.4K ﹤0.01% 4935
2022
Q3
$1K Buy
+1,400
New +$1.12K ﹤0.01% 9611
2022
Q2
Sell
-2,800
Closed -$2K 10859
2022
Q1
$2K Sell
2,800
-3,000
-52% -$10.1K ﹤0.01% 9910
2021
Q4
$46K Sell
5,800
-34,400
-86% -$262K ﹤0.01% 7372
2021
Q3
$266K Hold
40,200
﹤0.01% 5100
2021
Q2
$270K Buy
40,200
+39,308
+4,407% +$253K ﹤0.01% 5166
2021
Q1
$589K Buy
+892
New +$4.56K ﹤0.01% 3137
2020
Q4
Sell
-4
Closed -$1K 8907
2020
Q3
$1K Buy
+4
New +$21 ﹤0.01% 7584
2020
Q2
Sell
-16
Closed -$8K 8198
2020
Q1
$8K Buy
+16
New +$123 ﹤0.01% 6613
2019
Q2
Sell
-20
Closed -$27K 7628
2019
Q1
$27K Buy
+20
New +$299 ﹤0.01% 5499

Other funds holding PRQR

Simplex Trading's PRQR Position: Q1 2026 in Review

Simplex Trading reduced its ProQR Therapeutics (PRQR) stake by 44% in Q1 2026, selling an estimated $31.8K and leaving 24,868 shares worth $40.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6105.

Simplex Trading first reported a position in PRQR in Q1 2019 and has held it in 22 quarters since. The position peaked at $807K in Q1 2021. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

  • Simplex Trading held 24,868 shares of ProQR Therapeutics worth $40.3K as of Q1 2026.
  • Simplex Trading sold 19,401 ProQR Therapeutics shares in Q1 2026, an estimated $31.8K.
  • ProQR Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6105 holding.
  • Simplex Trading first reported a position in ProQR Therapeutics in Q1 2019 and has held it in 22 quarters since.
  • Simplex Trading's ProQR Therapeutics position peaked at $807K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.